Lifitegrast 5.0%, a topical anti-inflammatory therapy, effectively reduces signs and biomarkers of dry eye disease in 12 ...

Customizable scleral lenses can improve visual acuity and comfort in patients with a variety of corneal conditions.

NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.